Recent reports of the Congressional Research Service on topics related to openness and transparency include the following (all pdf).
“Does Price Transparency Improve Market Efficiency? Implications of Empirical Evidence in Other Markets for the Health Sector,” July 24, 2007.
“State E-Government Strategies: Identifying Best Practices and Applications,” July 23, 2007.
“Clinical Trials Reporting and Publication,” updated July 12, 2007.
“Freedom of Information Act Amendments: 110th Congress,” updated July 10, 2007.
No one will be surprised if we end up with a continuing resolution to push our shutdown deadline out past the midterms, so the real question is what else will they get done this summer?
Rebuilding public participation starts with something simple — treating the public not as a problem to manage, but as a source of ingenuity government cannot function without.
If the government wants a system of learning and adaptation that improves results in real time, it has to treat translation, utilization, and adaptation as core functions of governance rather than as afterthoughts.
Coordination among federal science agencies is essential to ensure government-wide alignment on R&D investment priorities. However, the federal R&D enterprise suffers from egregious siloization.